iORGAN Tech, a company based in Yangchenghu Peninsula Tourist Resort in SIP, is participating in a major national science and technology project on infectious disease control that was launched in Fudan University in Shanghai recently.

The project, titled “Research on High-Simulation HBV Infection Models and New Systems for Evaluating Curative Drugs”, is recommended by the National Health Commission, and led by Prof. Xie Youhua’s team at Fudan University’s School of Basic Medical Sciences.

iORGAN specializes in induced pluripotent stem cell (iPSC)-derived organoids. Through its internationally leading iPSC lineage co-differentiation technology, the company has advanced traditional organoids in lineage, structure and function. It is committed to providing complete solutions for basic research and drug development.

February 12, 2026